从脾胃论治呼吸系统疾病研究进展:基于中医药调节肠道菌群  

Research Progress of Traditional Chinese Medicine Based on Intestinal Flora in the Treatment of Respiratory Diseases from the Spleen and Stomach

作　　者：周怡菲 刘锐[2] 黄健华 刘丽[1] 陈波[1] Zhou Yifei;Liu Rui;Huang Jianhua;Liu Li;Chen Bo(Graduate School,Guangxi University of Chinese Medicine,Nanning 530000,China;Department of Respiratory and Critical Care Medicine,Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine,Nanning 530000,China)

机构地区：[1]广西中医药大学研究生院,广西南宁530000 [2]广西中医药大学附属瑞康医院呼吸与危重症医学科,广西南宁530000

出　　处：《亚太传统医药》2023年第6期231-235,共5页Asia-Pacific Traditional Medicine

摘　　要：肠道菌群对维持人体健康至关重要,人体的呼吸道、肠道寄生着大量的微生物。研究表明,肠道菌群失调可引起呼吸系统疾病,基于中医的“肺与大肠相表里”理论及脾胃论治法,中药调节肠道菌群可起到防治呼吸系统疾病之效,其作用机制与减轻炎症反应、调节免疫反应、减少毒素吸收等有关。围绕肠道菌群与呼吸系统疾病的相关性,探讨中医药调节肠道菌群防治肺部疾病的作用机制,以期为临床防治呼吸系统疾病提供新思路。The intestinal flora is essential for maintaining human health,and a large number of microorganisms are parasitic in the human respiratory tract and intestines.Studies have shown that intestinal dysbiosis can cause respiratory diseases.Based on the theory of"lung and large intestine phase"and the spleen and stomach theory of traditional Chinese medicine,the regulation of intestinal flora by Traditional Chinese medicine can play a role in preventing and treating respiratory diseases.Its mechanism of action is related to reducing the inflammatory response,regulating the immune response,reducing the absorption of toxins.Focusing on the correlation between intestinal microbiota and respiratory diseases,this paper discusses the mechanism of traditional Chinese medicine in regulating the prevention and treatment of lung diseases by intestinal microbiota,in order to provide new ideas for the clinical prevention and treatment of respiratory diseases.

关 键 词：中药 肠道菌群 从脾胃论治 呼吸系统疾病 

分 类 号：R256.1[医药卫生—中医内科学]